Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2016

Aug 4, 2016

33869_rns_2016-08-04_493f3b5f-6a50-4598-be54-9f89460f44fe.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Admedus Ltd ABN 35 088 221 078

REGISTERED OFFICE: 26 Harris Road Malaga Western Australia 6090

==> picture [226 x 82] intentionally omitted <==

ASX ANNOUNCEMENT

PO Box 6879 East Perth Western Australia 6892 T +61 (0)8 9266 0100 F +61 (0)8 9266 0199 E [email protected]

www.admedus.com

NOTICE UNDER SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001

5 August 2016

On 5 August 2016 2016, Admedus Limited ( Company ) issued 30,303,031 fully paid ordinary shares in the capital of the Company ( Shares ) to sophisticated and institutional investors at a price of $0.33 per Share to raise $10 million (before costs) ( Placement ). Further details of the Placement are in the Company's announcement lodged with the ASX on 29 July 2016.

The Corporations Act 2001 (Cth) ( Corporations Act ) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Corporations Act. By the Company giving this notice, a sale of the Shares will fall within the exemption in section 708A(5) of the Corporations Act.

The Company hereby gives notice under section 708A(5)(e) of the Corporations Act that:

  • (a) the Company issued the Shares under the Placement without disclosure under Part 6D.2 of the Corporations Act;

  • (b) as at the date of this notice, the Company has complied with:

    • (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

    • (ii) section 674 of the Corporations Act;

  • (c) as at the date of this notice, there is no information:

    • (i) that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

    • (ii) that investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

      • (A) the assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

      • (B) the rights and liabilities attaching to the Shares.

Yours faithfully

==> picture [93 x 33] intentionally omitted <==

Mr. Wayne Paterson Chairman and Interim CEO

==> picture [595 x 44] intentionally omitted <==